http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H05279344-A
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-545 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-48 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D- http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-545 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-54 |
filingDate | 1993-01-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 1993-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-H05279344-A |
titleOfInvention | N-5-protected 2,5-diamino-4,6-dichloropyrimidine and process for producing the same |
abstract | (57) [Summary] (Modified) [Purpose] N-5-protected 2,5-diamino-of formula I Provided is an improved process for making 4,6-dichloropyrimidine. The N-protected aminomalonic acid ester of formula II is cyclized with guanidine in the presence of an alkali alcoholate to an N-5-protected 4,6-dihydroxy-2,5-diaminopyrimidine of formula III, which is obtained A compound of formula I by chlorination of the compound with phosphorus oxychloride, And compounds of formula I. [Wherein R is an alkoxy group or CF 3 and R 1 is C Meaning 1 to 4 lower alkyl groups] [Effect] The compound of formula I is an intermediate for producing a drug having antiviral properties. |
priorityDate | 1992-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Predicate | Subject |
---|---|
isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19094597 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID234277612 |
Total number of triples: 16.